title: [Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].
authors.affiliation: III. Medizinische Universitätsklinik Mannheim, Universität Heidelberg. eva.lengfelder@med3.ma.uni-heidelberg.de
authors.forename: E
authors.initials: E
authors.lastname: Lengfelder
authors.forename: B
authors.initials: B
authors.lastname: Schultheis
authors.forename: T
authors.initials: T
authors.lastname: Büchner
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D017209:Apoptosis; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D010087:Oxides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction / Q000379:methods; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide